Our Team Members

Christopher T. Griffith


Chris is a founding partner of Green Griffith. As a seasoned IP trial lawyer with over 30 years experience in IP law, Chris concentrates his practice in pharmaceuticals, chemicals, medical devices and biotechnology. He has been lead counsel in trials and appeals, representing both patentees and defendants before the U.S. District Courts and the Federal Circuit.

A Hatch-Waxman expert, he partners with clients to provide strategic formulation, portfolio and pre-litigation counseling concerning IP and related FDA issues affecting 505(b)(1), 505(b)(2) and ANDA applications.

With expertise gained by representing brand and generic companies, he provides strategies and opinions (validity, freedom-to-operate) directed toward attaining client goals, whether this involves API/excipient selection, trade dress, formulation attributes, or labeling, and then works with clients to execute the desired strategy – whether this involves litigation in the federal courts (Paragraph IV and/or Section viii), IPRs or arbitration.

Chris and his team are also skilled in inter partes reviews (IPRs), as well as in reexaminations, reissues and post-grant proceedings under the AIA.

He has significant experience in navigating the 505(b)(2) pathway, including advising clients on PIV certifications, Orange Book issues, related FDA issues, and portfolio development. Due diligence is also a strength.

Chris enjoys lecturing and teaching, and is a former adjunct professor at The John Marshall Law School, where he developed a Master's level course in patent law, and taught that course for many years.

Prior to co-founding Green Griffith in 2015, Chris was Corporate Secretary of Leydig, Voit & Mayer, Ltd. and served on its Board of Directors.


University of Houston, J.D. 
Michigan State University, B.S. in Chemical Engineering
Johns Hopkins University, Graduate Coursework in Biotechnology

Professional Affiliations

Court Admissions


Representative Matters

Speaking Engagements and Presentations